Title: Jacob Gunn E Glanville: Innovator in Antibody Technology
Introduction
Jacob Gunn E Glanville is a notable inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the development of methods for humanizing antibodies derived from rabbits. His innovative approach aims to enhance the efficacy of therapeutic antibodies for human use.
Latest Patents
Jacob Gunn E Glanville holds a patent titled "Method For Mass Humanization Of Rabbit Antibodies." This invention relates to a method for producing a population of 20 or more nucleic acids, each encoding at least one protein comprising at least one immunoglobulin variable domain. These domains have a rabbit-derived CDR3 amino acid sequence embedded in essentially human framework sequences. The patent also encompasses a population of nucleic acids and proteins related to this method and their various uses.
Career Highlights
Jacob is currently associated with Distributed Bio, Inc., a company that focuses on the development of antibody therapeutics. His work at Distributed Bio has positioned him as a key player in the biotechnology sector, where he continues to push the boundaries of antibody engineering.
Collaborations
Jacob collaborates with Vera Molkenthin, who is also involved in the innovative projects at Distributed Bio. Their combined expertise contributes to the advancement of antibody technologies and therapeutic applications.
Conclusion
Jacob Gunn E Glanville is a pioneering inventor whose work in antibody humanization is shaping the future of biotechnology. His contributions are vital for the development of effective therapeutic solutions.